Compare ROAD & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ROAD | PTCT |
|---|---|---|
| Founded | 2001 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Engineering & Construction | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 6.1B |
| IPO Year | 2018 | 2013 |
| Metric | ROAD | PTCT |
|---|---|---|
| Price | $110.69 | $75.18 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 17 |
| Target Price | ★ $122.20 | $73.76 |
| AVG Volume (30 Days) | 437.5K | ★ 1.2M |
| Earning Date | 02-05-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 40.46 | N/A |
| EPS | 1.84 | ★ 8.94 |
| Revenue | ★ $2,812,356,000.00 | $1,779,150,000.00 |
| Revenue This Year | $25.23 | $129.80 |
| Revenue Next Year | $10.22 | N/A |
| P/E Ratio | $61.28 | ★ $8.53 |
| Revenue Growth | 54.20 | ★ 97.54 |
| 52 Week Low | $64.79 | $35.95 |
| 52 Week High | $138.90 | $87.50 |
| Indicator | ROAD | PTCT |
|---|---|---|
| Relative Strength Index (RSI) | 47.74 | 47.95 |
| Support Level | $110.53 | $73.77 |
| Resistance Level | $114.50 | $77.55 |
| Average True Range (ATR) | 4.90 | 3.50 |
| MACD | -0.38 | -0.10 |
| Stochastic Oscillator | 32.16 | 53.42 |
Construction Partners Inc operates as a civil infrastructure company. It specializes in the construction and maintenance of roadways. The company through its subsidiaries, provides various products and services to both public and private infrastructure projects, with an emphasis on highways, roads, bridges, airports, and commercial and residential developments. Its operations consist of manufacturing and distributing hot mix asphalt, paving activities, including the construction of roadway base layers and application of asphalt pavement, site development, including the installation of utility and drainage systems, and others. The company has a single segment which predominantly consists of infrastructure and road construction, and operates across various states in the United States.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.